Results 21 to 30 of about 65,300 (300)

Desymmetrization of Pibrentasvir for Efficient Prodrug Synthesis

open access: yes, 2021
A novel and practical desymmetrization tactic is described to access a new class of pibrentasvir prodrugs. The homotopic benzimidazoles of pibrentasvir (PIB) are differentiated via a one-pot di-Boc/mono-de-Boc selective N-Boc protection and formaldehyde ...
Jan E., Waters   +8 more
core   +1 more source

Biodistribution and Pharmacokinetics of O-Palmitoyl Tilisolol, a Lipophilic Prodrug of Tilisolol, after Intravenous Administration in Rats [PDF]

open access: yes, 2002
The purpose of this study was to modify the biodistribution and pharmacokinetics of tilisolol, a β-blocker, using the palmitoyl prodrug approach. After intravenous administration of tilisolol and O-palmitoyl tilisolol in rats, drug concentrations were ...
Sasaki, Hitoshi   +10 more
core   +1 more source

Synthesis, In Vitro and In Vivo Evaluation of the N-ethoxycarbonylmorpholine Ester of Diclofenac as a Prodrug

open access: yesPharmaceuticals, 2014
The N-ethoxycarbonylmorpholine moiety was evaluated as a novel prodrug moiety for carboxylic acid containing drugs represented by diclofenac (1).
Jamal A. Jilani   +2 more
doaj   +1 more source

A New Classification of Prodrugs: Regulatory Perspectives

open access: yesPharmaceuticals, 2009
Many therapeutic agents are manufactured and administered in prodrug forms. In this paper, a new classification system for prodrugs is proposed to provide useful information about where in the body a prodrug is converted to the active drug.
Kuei-Meng Wu
doaj   +1 more source

Cyclization-activated Prodrugs [PDF]

open access: yesMolecules, 2007
Many drugs suffer from an extensive first-pass metabolism leading to druginactivation and/or production of toxic metabolites, which makes them attractive targets forprodrug design. The classical prodrug approach, which involves enzyme-sensitive covalentlinkage between the parent drug and a carrier moiety, is a well established strategy toovercome ...
Paula Gomes, Nuno Vale, Rui Moreira
openaire   +5 more sources

Reduction-Responsive Stearyl Alcohol-Cabazitaxel Prodrug Nanoassemblies for Cancer Chemotherapy

open access: yesPharmaceutics, 2023
Cabazitaxel (CTX) has distinct therapeutic merits for advanced and metastatic cancer. However, the present clinical formulation (Jevtana®) has several defects, especially for undesirable tumor-targeting and serious side effects, greatly limiting the ...
Yuting Liu   +6 more
doaj   +1 more source

Self-Assembled Disulfide Bond Bearing Paclitaxel—Camptothecin Prodrug Nanoparticle for Lung Cancer Therapy

open access: yesPharmaceutics, 2020
Self-assembled prodrugs (SAPDs), which combine prodrug strategy and the merits of self-assembly, not only represent an appealing type of therapeutics, enabling the spontaneous organization of supramolecular nanocomposites with defined structures in ...
Jingyan Gao   +7 more
doaj   +1 more source

Antibody-based Imaging of Bioreductive Prodrug Release in Hypoxia

open access: yes, 2023
Regions of hypoxia occur in most tumors and predict for poor patient prognosis. Hypoxia-activated prodrugs provide an ideal strategy to target the aggressive, hypoxic fraction of a tumor while protecting the normal tissue from toxicity.
Antoine, Wallabregue   +6 more
core   +1 more source

Design, Synthesis and Kinetic Study of Coumarin-Based Mutual Prodrug of 5-Fluorouracil and Dichloroacetic acid

open access: yesIraqi Journal of Pharmaceutical Sciences, 2017
On the basis of known coumarin-based prodrug system, a novel coumarin-based mutual prodrug of 5-fluorouracil and dichloroacetic acid was designed, synthesized and evaluated as a promising oral chemotherapeutic agent basing on in vitro stability study in ...
Yasser F. Mustafa, Nohad A. Al-Omari
doaj   +3 more sources

A CNS-Targeting Prodrug Strategy for Nuclear Receptor Modulators

open access: yes, 2020
Neurodegenerative diseases lack a breadth of treatment options due, in part, to the known difficulties associated with a drug’s passage across the blood-brain barrier.
Skylar, Ferrara, Thomas, Scanlan
core   +1 more source

Home - About - Disclaimer - Privacy